@article {Golden:2018:2637-8329:188,
title = "Solitary Fibrous Tumor/Hemangiopericytoma: A Companion Case Discussion of a Spectrum of Rare CNS Mesenchymal Tumors and Their Evolving WHO Classification",
journal = "Neurographics",
parent_itemid = "infobike://asnr/ng",
publishercode ="asnr",
year = "2018",
volume = "8",
number = "3",
publication date ="2018-06-01T00:00:00",
pages = "188-192",
itemtype = "ARTICLE",
issn = "2637-8329",
eissn = "2637-8329",
url = "https://asnr.publisher.ingentaconnect.com/content/asnr/ng/2018/00000008/00000003/art00003",
doi = "doi:10.3174/ng.1700039",
keyword = "NAB2 = nerve growth factor inducible-A-binding protein 2, WHO = World Health Organization, MMA = middle meningeal artery, ECA = external carotid artery, STAT6 = signal transducer and activator of transcription 6, HPC = hemangiopericytoma, SFT = solitary fibrous tumor, STA = superficial temporal artery",
author = "Golden, K.T. and Sun, Y. and Li, T. and Bobra, S. and Mehta, H.",
abstract = "The combined term solitary fibrous tumor/hemangiopericytoma was recently introduced in the World Health Organization Classification of Tumors of the Central Nervous System 2016 revision. The consolidation came amid mounting evidence that these 2 mesenchymal tumors are closely related,
or even identical, entities. These neoplasms demonstrate significant clinical and demographic overlap, often indistinguishable imaging features, and a shared nerve growth factor inducible-A-binding protein 2/signal transducer and activator of transcription 6 gene fusion. We presented 2 cases
of this uncommon entity and discussed its evolving tumor classification.",
}